ArticleRespiratory medicine2025
Socioeconomic disparities in inpatient outcomes among US pediatric asthma hospitalizations.
Article in Respiratory medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Natural medicines for asthma management: mechanisms aligned with endotypes and multi-dimensional intervention.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveThis study estimates the cost and length of stay (LOS) of pediatric asthma hospitalizations in the US; examines disparities in LOS and cost according to income; and quantifies the proportion of this relationship mediated by individual, environmental, and community factors.
methodsCross-sectional data from the US National Inpatient Sample (2016-2019) were used to examine the hospital service delivery cost (USD 2020) and LOS (days) of pediatric (5-17 years) asthma admissions, N = 150,845. Disparities in cost and LOS according to income were estimated. Causal mediation analysis was used to quantify the role of potential mediators (asthma severity, comorbidity, tobacco/smoke exposure, insurance, or hospital capacity) in explaining disparities.
resultsThe total cost of admissions was $260 million annually. The average cost and LOS per admission were $6884 (95 %CI: 6682, 7086) and 2 days (95 %CI: 2.09, 2.15). Individuals living in lower income areas had a 3 % increase in LOS and a 3 % decrease in costs per admission compared to those who live in higher-income areas. Severe persistent asthma and exposure to smoke/tobacco mediated the largest proportion of disparities between the income-LOS (20 % & 17 %) and income-cost (-29 % & -21 %) relationships. Hospital capacity was the only positive mediator between income and cost (10 %).
conclusionPediatric patients from lower income areas have longer LOS and lower costs compared to those from higher income areas. Interventions to eliminate income-related differences in asthma severity and smoke/tobacco exposure may narrow LOS disparities while widening cost disparities; revealing even lower costs among lower income patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.